0001127602-19-007865.txt : 20190225
0001127602-19-007865.hdr.sgml : 20190225
20190225093613
ACCESSION NUMBER: 0001127602-19-007865
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150210
FILED AS OF DATE: 20190225
DATE AS OF CHANGE: 20190225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ellingwood Dwight E
CENTRAL INDEX KEY: 0001614529
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14902
FILM NUMBER: 19628253
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC
CENTRAL INDEX KEY: 0000794172
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 310888197
STATE OF INCORPORATION: OH
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 3471 RIVER HILLS DR
CITY: CINCINNATI
STATE: OH
ZIP: 45244
BUSINESS PHONE: 5132713700
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
FORMER COMPANY:
FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-02-10
0000794172
MERIDIAN BIOSCIENCE INC
VIVO
0001614529
Ellingwood Dwight E
3471 RIVER HILLS DRIVE
CINCINNATI
OH
45244
1
Common Stock
2015-02-10
4
P
0
33
18.1998
A
3013
D
Common Stock
2015-05-11
4
P
0
32
18.5148
A
3045
D
Common Stock
2015-08-10
4
P
0
32
18.6911
A
3077
D
Common Stock
2015-11-23
4
P
0
32
19.2658
A
3109
D
Common Stock
2016-02-12
4
P
0
32
19.6196
A
3141
D
Common Stock
2016-05-16
4
P
0
33
19.0604
A
3174
D
Common Stock
2016-08-15
4
P
0
32
19.5009
A
6206
D
Common Stock
2016-11-28
4
P
0
38
17.065
A
6244
D
Common Stock
2017-02-13
4
P
0
41
12.9286
A
7305
D
Common Stock
2017-05-15
4
P
0
36
14.8972
A
7341
D
Common Stock
2017-08-14
4
P
0
39
13.938
A
7380
D
Common Stock
2017-11-28
4
P
0
38
14.5607
A
7418
D
Common Stock
2018-02-13
4
P
0
39
14.1311
A
7457
D
Common Stock
2018-05-15
4
P
0
40
13.8794
A
7497
D
Common Stock
2018-08-16
4
P
0
38
14.9125
A
7535
D
Common Stock
2018-11-28
4
P
0
31
18.4216
A
8566
D
Common Stock
2019-02-21
4
J
0
981
0
D
0
D
Common Stock
2019-02-21
4
J
0
981
0
A
9547
D
Share purchases reflected on this Form were acquired via a Dividend Reinvestment Plan ("DRIP") beginning in February 2015 and ceasing in November 2018.
Following the January 24, 2019 grant of 981 restricted stock units (as reported on Form 4 filed January 28, 2019), Common Stock holdings currently total 9,547.
/s/ Bryan T. Baldasare as Attorney-in-Fact for Dwight Ellingwood
2019-02-25